Author

Dan Zhang

h-index 0 View on Semantic Scholar

We have 2 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Real-world safety profile of finerenone in patients with type 2 diabetes and chronic kidney disease: a multi-database pharmacovigilance analysis of the FAERS and JADER systems

Finerenone, a novel nonsteroidal mineralocorticoid receptor antagonist, has been shown to lower the risk of renal and cardiovascular events in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). However, real-world safety data beyond clinical trials remain limited, particularly regarding...

Dan Zhang, Yun Zhao, Hai-Ting Chen et al. · Frontiers in Clinical Diabet... · 0 citations

Open access Jul 2026

A multicomponent intervention incorporating CYP2C19 genotype-guided therapy and integrated pharmaceutical care reduces hospitalizations and improves adherence in ischemic stroke

A multicomponent intervention comprising CYP2C19 genotype-guided therapy and intensive pharmacist-led integrated pharmaceutical care significantly improved medication adherence and reduced hospitalization frequency, with more pronounced benefits observed in patients at high risk of stroke recurrence, without increasing...

Dan Zhang, Zhongru Meng, Yu-fei Li et al. · Frontiers in Neurology · 0 citations